ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,905.13
-0.26%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Fennec Pharmaceuticals Inc (FENC)

  7. Fennec Pharmaceuticals Inc (FENC) ニュース

FENC

Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FENC
日付受信時刻ニュースソース見出しコード企業名
2024/05/1506 : 24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
2024/05/1419 : 03GlobeNewswire Inc.Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
2024/05/1405 : 42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FENCFennec Pharmaceuticals Inc
2024/05/0807 : 15GlobeNewswire Inc.Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
2024/03/2119 : 00GlobeNewswire Inc.Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
2024/03/1919 : 01GlobeNewswire Inc.Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
2024/03/1816 : 00PR Newswire (US)Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
2024/03/1810 : 00GlobeNewswire Inc.Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
2024/03/0706 : 07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FENCFennec Pharmaceuticals Inc
2024/03/0106 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FENCFennec Pharmaceuticals Inc
2024/02/2921 : 04GlobeNewswire Inc.Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsNASDAQ:FENCFennec Pharmaceuticals Inc
2024/02/1500 : 47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FENCFennec Pharmaceuticals Inc
2024/02/0119 : 55GlobeNewswire Inc.FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving CisplatinNASDAQ:FENCFennec Pharmaceuticals Inc
2024/01/0607 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2024/01/0606 : 45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2024/01/0506 : 42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/12/3006 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/12/2905 : 51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/12/1814 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FENCFennec Pharmaceuticals Inc
2023/12/0519 : 55GlobeNewswire Inc.Fennec Announces Incremental $5 Million Investment from PetrichorNASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/1706 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/1006 : 56Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/1006 : 52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/1006 : 50GlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/1006 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/0908 : 19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/0619 : 59GlobeNewswire Inc.Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
2023/11/0406 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
2023/10/3019 : 45GlobeNewswire Inc.Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:FENCFennec Pharmaceuticals Inc
2023/09/0718 : 59GlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:FENC

最近閲覧した銘柄

GATE
UPIUSDT
Pawtocol Network UPI Token
BIT
UR9KFZ
UniCredit Bank
EU
ALOAD
Alstom SA Alstom Sa Obli...
BOV
BRFSL14
BRFSL14 Ex:14
EU
COR30
Euronext Core Europe EW3...
LSE
11BM
TSXV
VRD.H
Viridis
LSE
NLB
Nova Ljubljanska banka d...
ASX
NABIWK
COIN
WITKNGBP
NASDAQ
DWIRD
BIT
UV8CP0
UniCredit Bank
USOTC
ABBRF
AbraSilver Resource (QX)
LSE
44IO
Hend.smll.4h%pf
TG
L7T
UniDoc Health
TSXV
ENTG
Entourage Health
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有